SCHEMBL1374563

SCHEMBL1374563

CCN(C)C(=O)CCOC(C)C

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.33
LMNA P02545 1/20 0.31
TP53 P04637 1/20 0.30
PKM P14618 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1374437 0.85
SCHEMBL1376712 0.85 EPHX2 (0.33) ALDH1A1LMNA
SCHEMBL25089679 0.82 MEN1 (0.34) ALDH1A1
SCHEMBL1377034 0.82 LMNA (0.52) ALDH1A1LMNA
SCHEMBL1375728 0.81 CHRNB2 (0.45) ALDH1A1TP53PKM
SCHEMBL16467073 0.78 MEN1 (0.33) ALDH1A1LMNA
SCHEMBL16467044 0.78 TP53 (0.33) ALDH1A1TP53PKM
SCHEMBL16467135 0.77 HSD17B10 (0.32)
SCHEMBL1375496 0.77 LMNA (0.39) ALDH1A1LMNA
SCHEMBL1375732 0.77 ALDH1A1 (0.41) ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12037503-B2 Ink jet ink composition and recording method SEIKO EPSON CORPORATION (JP) 2024-07-16 US disclosed
US-11904615-B2 Recording method and ink jet recording apparatus SEIKO EPSON CORPORATION (JP) 2024-02-20 US disclosed
US-11866601-B2 Ink set and printing method SEIKO EPSON CORPORATION 2024-01-09 US disclosed
US-20230312945-A1 Pigment Composition And Coloring Method SEIKO EPSON CORPORATION (JP) 2023-10-05 US disclosed
US-20230303866-A1 Coloring Composition, Coloring Method, And Pigment Dispersion SEIKO EPSON CORPORATION (JP) 2023-09-28 US disclosed
US-20230303848-A1 Coloring Composition, Coloring Method, And Pigment Dispersion SEIKO EPSON CORPORATION (JP) 2023-09-28 US disclosed
US-20230279255-A1 Coloring Composition, Coloring Method, And Pigment Dispersion SEIKO EPSON CORPORATION (JP) 2023-09-07 US disclosed
US-11578224-B2 Ink set SEIKO EPSON CORPORATION 2023-02-14 US disclosed
US-11577538-B2 Ink jet recording method and ink jet recording apparatus SEIKO EPSON CORPORATION 2023-02-14 US disclosed
US-11572485-B2 Ink set SEIKO EPSON CORPORATION 2023-02-07 US disclosed
EP-2824150-B1 Inkjet ink set and image forming method FUJIFILM CORP (JP) 2017-09-20 EP disclosed
EP-2902454-B1 INK COMPOSITION, INK SET, AND IMAGE FORMING METHOD FUJIFILM CORP (JP) 2017-04-19 EP disclosed
US-9346968-B2 Ink composition, ink set, and image forming method FUJIFILM CORPORATION (JP) 2016-05-24 US disclosed
EP-2902454-A1 INK COMPOSITION, INK SET, AND IMAGE FORMING METHOD Fujifilm Corporation (JP) 2015-08-05 EP disclosed
US-20150175819-A1 INK COMPOSITION, INK SET, AND IMAGE FORMING METHOD FUJIFILM CORPORATION (JP) 2015-06-25 US disclosed
US-20150119604-A1 METHOD FOR PRODUCING BETA-ALKOXYPROPIONAMIDE IDEMITSU KOSAN CO., LTD. (JP) 2015-04-30 US disclosed
EP-2837619-A1 METHOD FOR PRODUCING BETA -ALKOXYPROPIONAMIDE Idemitsu Kosan Co., Ltd (JP) 2015-02-18 EP disclosed
EP-2824150-A1 Inkjet ink set and image forming method FUJIFILM Corporation (JP) 2015-01-14 EP disclosed
US-8563495-B2 Resist remover composition and method for removing resist using same IDEMITSU KOSAN CO., LTD. (JP) 2013-10-22 US disclosed
US-20110287995-A1 RESIST REMOVER COMPOSITION AND METHOD FOR REMOVING RESIST USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2011-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11578224-B2 Ink set SETDB1, ASH2L, MARK1 ALDH1A1 2322/4885LMNA 3520/4885TP53 312/4885
US-20150119604-A1 METHOD FOR PRODUCING BETA-ALKOXYPROPIONAMIDE HACL2, APEH, NAAA ALDH1A1 448/4885LMNA 792/4885TP53 4614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.